Abstract:Abstract Background To explore the application value of chromosomal microarray analysis (CMA) in prenatal diagnosis. Methods The results of chromosome karyotype analysis and CMA of 477 cases undergoing amniocentesis were analyzed. The results of the no ultrasound abnormality group and the ultrasound abnormality group were compared separately. Within the ultrasound abnormality group, the results of the ultrasound structural malformation group, the ultrasound soft index abnormality group, and other ultrasound abnormality (including abnormal amniotic fluid volume and fetal growth restriction) groups were compared. Results Abnormal chromosome and CMA results were found in a total of 71 cases (15.88%, 71/447), which can be broken down into a total of 23 karyotype abnormalities (5.15%, 23/447), consisting of 18 cases of aneuploidy (4.03%, 18/447), 2 cases of unbalanced chromosome rearrangements (0.44%, 2/447), and 3 cases of chimerism (0.67%, 3/447); 17 cases with detection of pathogenic copy number variations (pCNVs) (3.80%, 17/447); and 31 cases of detection of clinical variants of unknown significance (VOUS) (6.93%, 31/447). CMA detected 3.8% more genetic abnormalities than karyotype analysis (in addition to the abnormalities detected simultaneously by karyotype analysis). Between the no ultrasound abnormality group and the ultrasound abnormality group, there was an extremely significant difference in the detection rate of an abnormal chromosomal karyotype ( P 0.05). Comparing the ultrasound structural malformation group, the ultrasound soft index abnormality group, and the other ultrasound abnormality group, there were no significant differences in the detection rate of abnormal chromosomal karyotypes ( P > 0.05), pCNV ( P > 0.05) or VOUS ( P > 0.05). Conclusions The detection rate of chromosomal karyotype abnormalities in prenatal diagnosis in cases with no ultrasound abnormalities was higher. For cases with fetal ultrasound structural abnormalities, when compared with traditional karyotype analysis, CMA can improve the detection rate of fetal genetic abnormalities. However, the no ultrasound abnormality group also had a high VOUS abnormality detection rate, so it is necessary to strictly define the CMA indications.

Cytogenomic microarray analysis is not the only solution to fetal karyotyping

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

External Quality Assessment of Prenatal Diagnosis of a Rare and Subtle Chromosomal Structural Abnormality.

An External Quality Assessment Scheme for Prenatal Detection of Rare Chromosomal Abnormalities

Application of chromosome microarray analysis in prenatal diagnosis

Assessment of Combined Karyotype Analysis and Chromosome Microarray Analysis in Prenatal Diagnosis: A Cohort Study of 3710 Pregnancies

Interfering effect of maternal cell contamination on invasive prenatal chromosome microarray analysis

Chromosomal microarray analysis for prenatal diagnosis of uniparental disomy: a retrospective study

Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies

The yield of SNP microarray analysis for fetal ultrasound cardiac abnormalities

Should chromosomal microarray be offered to fetuses with ultrasonographic soft markers in second trimester: A prospective cohort study and meta-analysis

Chromosomal abnormalities detected by chromosomal microarray analysis and pregnancy outcomes of 4211 fetuses with high-risk prenatal indications

Retrospective study revealed integration of CNV-seq and karyotype analysis is an effective strategy for prenatal diagnosis of chromosomal abnormalities

Clinically significant findings in a decade‐long retrospective study of prenatal chromosomal microarray testing

Low-pass Genome Sequencing Versus Chromosomal Microarray Analysis: Implementation in Prenatal Diagnosis

Standardization and Diversification of Copy Number Microarray Testing for Clinical Diagnostics—Implications of the Cross-Platform/Algorithm Study on Clinical Diagnostic Chromosomal Microarray Analysis

Chromosomal Microarray Analysis in Fetuses with Ultrasound Abnormalities

Comparison of Efficiencies of Non-invasive Prenatal Testing, Karyotyping, and Chromosomal Micro-Array for Diagnosing Fetal Chromosomal Anomalies in the Second and Third Trimesters.

Clinical value of screening prenatal ultrasound combined with chromosomal microarrays in prenatal diagnosis of chromosomal abnormalities

Comparison of Chromosomal Microarray Analysis and Noninvasive Prenatal Testing in Pregnant Women with Fetal Ultrasonic Soft Markers

Analysis of Prenatal Diagnosis Results of 338 Cases with Positive Non-Invasive DNA Test